Advertisment
|
|
|
news roundup
China-based Henlius Biotechnology has selected Medidata’s Medidata Clinical Cloud® platform for its Phase III oncology clinical trial in China.
|
advertisment
Mitigating risk using Risk-based Monitoring
On demand
Learn how risk-based monitoring (RBM) is transforming clinical development by mitigating risk while optimizing execution. Understand how to achieve enhanced patient safety with improved quality to execute your RBM studies with confidence.
 Read more
|
The approach can speed up development for treatments for unmet needs, while cutting costs and risks because it relies on compounds that have already been tested, but it raises questions for regulators.
|
advertisment
Acquiring, Tracking and Maintaining Biological Study Samples for Complex Study Designs
On Demand
 Read more
|
The Mexico office expands Eurotrials reach in Latin America and will specialize in strategic consulting, clinical studies conduct, project management, and outcome research.
Duke Clinical Research Institute (DCRI) examined the early use of platforms designed to provide access to individual patient data, developed to increase transparency of clinical trial data, and found the use has been limited.
|
|
|
|
advertisment
Advancing Drug Development with Digital Health
4 Key Ways to integrate Patient - Generated Data into Trials
On Demand
 Read more
|
Subscribe
|
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »
|
|
|
|
advertisment
Introducing A Faster, Easier, and More Effective Approach to Risk-Based Monitoring
On Demand
Oracle Health Sciences' holistic, advanced clinical trial solutions for data collection, management, and analysis help optimize research, mitigate risk, monitor/report adverse events, and drive medical insight for precision medicine
 Read more
|
|
Oncology
Schulman IRB will serve as the IRB of record for all participating research sites, and its IRB membership includes multiple oncologists and research professionals experienced in oncology research.
After test results are matched to treatments in MM LAB, the options are curated by the client laboratory's staff and included in the reports sent back to physicians and patients.
There is growing concern over confusion that has resulted from the emergence of more combination cancer treatments that now are regulated by different FDA Centers and are governed by different policies, procedures and statutory requirements.
|
|
|
Articles
The Fourth Industrial Revolution has the potential to transform clinical trials and thereby improve the quality and safety of life enhancing therapies and accelerate the pace with which they are brought to market.
|
|
Blog Posts
Precision trial optimization means understanding the performance and relative importance of literally hundreds of factors underlying each trial and identifying not simply “best practices” but “best practitioners.”
|
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription
|
|
|
|
|
